Ignite Creation Date:
2025-12-25 @ 1:19 AM
Ignite Modification Date:
2025-12-25 @ 11:28 PM
Study NCT ID:
NCT04890093
Status:
RECRUITING
Last Update Posted:
2025-04-15
First Post:
2021-05-15
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Vincristine and Temozolomide in Combination With PEN-866 for Adolescents and Young Adults With Relapsed or Refractory Solid Tumors
Sponsor:
National Cancer Institute (NCI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-10-31
Start Date Type:
ACTUAL
Primary Completion Date:
2026-02-28
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-12-31
Completion Date Type:
ESTIMATED
First Submit Date:
2021-05-15
First Submit QC Date:
None
Study First Post Date:
2021-05-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-04-12
Last Update Post Date:
2025-04-15
Last Update Post Date Type:
ACTUAL